Drugs / Peppermint essential oil
Peppermint essential oil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable1 trial | ||||||
| — | NCT03434340 | Jun 2018 → Mar 2019 | — | Universiti Kebangsaan Malaysia Medical Centre | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT04560114 Background | Dec 2020 → Sep 2021 | Athrombia, essential | Centre Francois Baclesse | Completed | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Peppermint essential oil | “Peppermint essential oil (Mentha x Piperita) and lemon tree essential oil (Citrus Limon).” NCT04560114 ↗ |
| Known as | Mentha x Piperita | “Peppermint essential oil (Mentha x Piperita) and lemon tree essential oil (Citrus Limon).” NCT04560114 ↗ |
| Known as | YoungLiving, 100% pure Peppermint essential oil | “YoungLiving®, 100% pure Peppermint essential oil” NCT03434340 ↗ |
| Action | Activate | “One of the proposed mechanism is by the activation of olfactory receptor” NCT03434340 ↗ |
| Route | Other | “2 drops applied on a nasal strip” NCT03434340 ↗ |